All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

6

Reset

6 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • VC005Phase 35 trials

    Jiangsu vcare pharmaceutical technology co., LTD · Non-segmental Vitiligo, Non-Segmental Vitiligo, Atopic Dermatitis

  • Jaktinib HydrochloridePhase 34 trials

    Suzhou Zelgen Biopharmaceuticals Co.,Ltd · Atopic Dermatitis, Ankylosing Spondylitis

  • LNK01001Phase 33 trials

    Lynk Pharmaceuticals Co., Ltd · Ankylosing Spondylitis, Atopic Dermatitis, Rheumatoid Arthritis

  • AK111Phase 32 trials

    Akeso · Psoriasis, Skin Diseases, Ankylosing Spondylitis

  • HS_SW01 cellsHS_SW01Phase 23 trials

    Shenzhen Huishan Biotechnology Co., Ltd. · Ankylosing Spondylitis, Primary Ovarian Insufficiency (Poi), Systemic Sclerosis (SSc)

  • vilamakitugXB2001, NatrunixPhase 22 trials

    XBiotech, Inc. · Axial Spondyloarthritis, Ankylosing Spondylitis, r-axSpA

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.